Exciting breakthroughs in the management of diabetes mellitus

• Published in: Diabetes epidemiology and management Vol. 1; p. 100005
• Main Author: Scheen, A.J.
• Format: Journal Article Web Resource
• Language: English
• Published: Elsevier Masson SAS 01.01.2021; Elsevier
• Subjects: Connected care; Endocrinologie, métabolisme & nutrition; Endocrinology, metabolism & nutrition; Human health sciences; Innovative technologies; Sciences de la santé humaine; Shared care; Telemedicine; Type 1 diabetes; Type 2 diabetes; Type 2 diabetes; Connected care; Telemedicine; Type 1 diabetes; Innovative technologies; Shared care
• ISSN: 2666-9706; 2666-9706
• DOI: 10.1016/j.deman.2021.100005

Remarkable advances were observed in recent years in the management of patients with type 2 (T2DM) or type 1 (T1DM) diabetes mellitus. Regarding T2DM, changes in treatment paradigms were observed, moving from a glucocentric approach to a multi-risk strategy and, finally, in people at high risk, to a specific cardiorenal protection using new antidiabetic agents. Regarding T1DM, progresses combined new insulin analogues with better pharmacokinetics, continuous and flash glucose monitoring and improved insulin delivery systems with smart insulin pens and insulin pumps connected to glucose monitoring device, allowing better glucose control with less hypoglycaemia. Because of an increasing variety of therapeutic approaches, an individualized patient-centred strategy is recommended, ideally with the collaboration of a multidisciplinary team. Shared care, connected care and tele-medicine will play an increasing role in the management of T1DM, and most probably also T2DM, in a near future.